Uplizna (inebilizumab)

pCPA File Number: 22632

Negotiation Status:

Under consideration for negotiation

Indication(s):

Neuromyelitis optica spectrum disorders (NMOSD)

Sponsor/Manufacturer:

Horizon Therapeutics Canada

CADTH Project Number:

SR0793-000

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable